{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T03:01:55Z","timestamp":1779850915609,"version":"3.53.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01245-8","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:14:00Z","timestamp":1778084040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0512-545X","authenticated-orcid":false,"given":"Hanna","family":"Kunina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9303-5947","authenticated-orcid":false,"given":"Jenny Y.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8741-2115","authenticated-orcid":false,"given":"Parag","family":"Garhyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne S.","family":"Geiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-9452","authenticated-orcid":false,"given":"Maria C.","family":"Kjellsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"04","key":"1245_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","volume":"10","author":"MZ Banday","year":"2020","unstructured":"Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: an overview. Avicenna J Med. 2020;10(04):174\u201388. https:\/\/doi.org\/10.4103\/ajm.ajm_53_20.","journal-title":"Avicenna J Med"},{"key":"1245_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1245_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","volume":"31","author":"JT Warshauer","year":"2020","unstructured":"Warshauer JT, Bluestone JA, Anderson MS. New frontiers in the treatment of type 1 diabetes. Cell Metab. 2020;31(1):46\u201361. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.017.","journal-title":"Cell Metab"},{"issue":"1","key":"1245_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. \u03b2-cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52(1):102\u201310. https:\/\/doi.org\/10.2337\/diabetes.52.1.102.","journal-title":"Diabetes"},{"issue":"1","key":"1245_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140\u20139. https:\/\/doi.org\/10.2337\/dc14-2441.","journal-title":"Diabetes Care"},{"issue":"4","key":"1245_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2337\/dc15-2035","volume":"39","author":"B Kovatchev","year":"2016","unstructured":"Kovatchev B, Cobelli C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care. 2016;39(4):502\u201310. https:\/\/doi.org\/10.2337\/dc15-2035.","journal-title":"Diabetes Care"},{"issue":"20","key":"1245_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/nu16203557","volume":"16","author":"N Den Braber","year":"2024","unstructured":"Den Braber N, Vollenbroek-Hutten MMR, Teunissen SEM, Oosterwijk MM, Kappert KDR, Laverman GD. The contribution of postprandial glucose levels to hyperglycemia in type 2 diabetes calculated from continuous glucose monitoring data: real world evidence from the DIALECT-2 cohort. Nutrients. 2024;16(20):3557. https:\/\/doi.org\/10.3390\/nu16203557.","journal-title":"Nutrients"},{"issue":"14","key":"1245_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","volume":"359","author":"WV Tamborlane","year":"2008","unstructured":"Tamborlane WV, Beck RW. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464\u201376. https:\/\/doi.org\/10.1056\/NEJMoa0805017.","journal-title":"N Engl J Med"},{"issue":"5","key":"1245_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","volume":"67","author":"M Jancev","year":"2024","unstructured":"Jancev M, Vissers TACM, Visseren FLJ, Van Bon AC, Sern\u00e9 EH, DeVries JH, et al. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2024;67(5):798\u2013810. https:\/\/doi.org\/10.1007\/s00125-024-06107-6.","journal-title":"Diabetologia"},{"key":"1245_CR10","doi-asserted-by":"publisher","unstructured":"Carlson AL, Mullen DM, Bergenstal RM. Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther. 2017;19(2_suppl). https:\/\/doi.org\/10.1089\/dia.2017.0024.","DOI":"10.1089\/dia.2017.0024"},{"key":"1245_CR11","doi-asserted-by":"publisher","DOI":"10.1515\/labmed-2018-0311","author":"G Freckmann","year":"2018","unstructured":"Freckmann G, Mende J. Continuous glucose monitoring: data management and evaluation by patients and health care professionals \u2013 current situation and developments. LaboratoriumsMed. 2018. https:\/\/doi.org\/10.1515\/labmed-2018-0311.","journal-title":"LaboratoriumsMed"},{"key":"1245_CR12","unstructured":"Medpace. Benefits and challenges of continuous glucose monitoring (CGM) in clinical development [Internet]. [cited 2025 Apr 2]. Available from: https:\/\/www.medpace.com."},{"issue":"2","key":"1245_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/19322968221113341","volume":"18","author":"G Freckmann","year":"2024","unstructured":"Freckmann G, Schauer S, Beltzer A, Waldenmaier D, Buck S, Baumstark A, et al. Continuous glucose profiles in healthy people with fixed meal times and under everyday life conditions. J Diabetes Sci Technol. 2024;18(2):407\u201313. https:\/\/doi.org\/10.1177\/19322968221113341.","journal-title":"J Diabetes Sci Technol"},{"key":"1245_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00673","volume":"9","author":"P Goel","year":"2018","unstructured":"Goel P, Parkhi D, Barua A, Shah M, Ghaskadbi S. A minimal model approach for analyzing continuous glucose monitoring in type 2 diabetes. Front Physiol. 2018;9:673. https:\/\/doi.org\/10.3389\/fphys.2018.00673.","journal-title":"Front Physiol"},{"issue":"2","key":"1245_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1932296814523878","volume":"8","author":"AH Hansen","year":"2014","unstructured":"Hansen AH, Duun-Henriksen AK, Juhl R, Schmidt S, N\u00f8rgaard K, J\u00f8rgensen JB, et al. Predicting plasma glucose from interstitial glucose observations using Bayesian methods. J Diabetes Sci Technol. 2014;8(2):321\u201330. https:\/\/doi.org\/10.1177\/1932296814523878.","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"1245_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/0091270009341185","volume":"50","author":"HE Silber","year":"2010","unstructured":"Silber HE, Frey N, Karlsson MO. An integrated glucose\u2010insulin model to describe oral glucose tolerance test data in healthy volunteers. J Clin Pharmacol. 2010;50(3):246\u201356. https:\/\/doi.org\/10.1177\/0091270009341185.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"1245_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.tips.2020.09.005","volume":"41","author":"I Irurzun-Arana","year":"2020","unstructured":"Irurzun-Arana I, Rackauckas C, McDonald TO, Troc\u00f3niz IF. Beyond deterministic models in drug discovery and development. Trends Pharmacol Sci. 2020;41(11):882\u201395. https:\/\/doi.org\/10.1016\/j.tips.2020.09.005.","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"1245_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/jamia\/ocz159","volume":"26","author":"M Zheng","year":"2019","unstructured":"Zheng M, Ni B, Kleinberg S. Automated meal detection from continuous glucose monitor data through simulation and explanation. J Am Med Inform Assoc. 2019;26(12):1592\u20139. https:\/\/doi.org\/10.1093\/jamia\/ocz159.","journal-title":"J Am Med Inform Assoc"},{"key":"1245_CR19","doi-asserted-by":"publisher","unstructured":"Palacios V, Woodbridge DMK, Fry JL. Machine learning-based meal detection using continuous glucose monitoring on healthy participants: an objective measure of participant compliance to protocol. In: 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) [Internet]. Mexico: IEEE; 2021 [cited 2026 Mar 19]. p. 7032\u20135. Available from: https:\/\/ieeexplore.ieee.org\/document\/9630408\/. https:\/\/doi.org\/10.1109\/EMBC46164.2021.9630408.","DOI":"10.1109\/EMBC46164.2021.9630408"},{"key":"1245_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1308348","volume":"10","author":"J Brummer","year":"2024","unstructured":"Brummer J, Glasbrenner C, Hechenbichler Figueroa S, Koehler K, H\u00f6chsmann C. Continuous glucose monitoring for automatic real-time assessment of eating events and nutrition: a scoping review. Front Nutr. 2024;10:1308348. https:\/\/doi.org\/10.3389\/fnut.2023.1308348.","journal-title":"Front Nutr"},{"issue":"14","key":"1245_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu16142214","volume":"16","author":"N Lubasinski","year":"2024","unstructured":"Lubasinski N, Thabit H, Nutter PW, Harper S. Blood glucose prediction from nutrition analytics in type 1 diabetes: a review. Nutrients. 2024;16(14):2214. https:\/\/doi.org\/10.3390\/nu16142214.","journal-title":"Nutrients"},{"issue":"11","key":"1245_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/dom.12712","volume":"18","author":"MJ Davies","year":"2016","unstructured":"Davies MJ, Russell-Jones D, Selam J-L, Bailey TS, Ker\u00e9nyi Z, Luo J, et al. Basal insulin peglispro versus insulin glargine in insulin-na\u00efve type 2 diabetes: IMAGINE 2 randomized trial. Diabetes Obes Metab. 2016;18(11):1055\u201364. https:\/\/doi.org\/10.1111\/dom.12712.","journal-title":"Diabetes Obes Metab"},{"key":"1245_CR23","unstructured":"World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation. Geneva, Switzerland: WHO Document Production Services; 2006. p. 50. Report No."},{"issue":"2","key":"1245_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143\u201351. https:\/\/doi.org\/10.1208\/s12248-011-9255-z.","journal-title":"AAPS J"},{"issue":"8","key":"1245_CR25","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/dc08-0545","volume":"31","author":"DM Nathan","year":"2008","unstructured":"Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473\u20138. https:\/\/doi.org\/10.2337\/dc08-0545.","journal-title":"Diabetes Care"},{"issue":"12","key":"1245_CR26","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631\u201340. https:\/\/doi.org\/10.2337\/dc17-1600.","journal-title":"Diabetes Care"},{"issue":"2","key":"1245_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0091270010362536","volume":"51","author":"PM Jauslin","year":"2011","unstructured":"Jauslin PM, Frey N, Karlsson MO. Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes. J Clin Pharmacol. 2011;51(2):153\u201364. https:\/\/doi.org\/10.1177\/0091270010362536.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"1245_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jcph.86","volume":"53","author":"MC Kjellsson","year":"2013","unstructured":"Kjellsson MC, Cosson VF, Mazer NA, Frey N, Karlsson MO. A model\u2010based approach to predict longitudinal HbA1c, using early phase glucose data from type 2 diabetes mellitus patients after anti\u2010diabetic treatment. J Clin Pharmacol. 2013;53(6):589\u2013600. https:\/\/doi.org\/10.1002\/jcph.86.","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"1245_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/jcph.270","volume":"54","author":"RM R\u00f8ge","year":"2014","unstructured":"R\u00f8ge RM, Klim S, Kristensen NR, Ingwersen SH, Kjellsson MC. Modeling of 24\u2010hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart. J Clin Pharmacol. 2014;54(7):809\u201317. https:\/\/doi.org\/10.1002\/jcph.270.","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"1245_CR30","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1177\/0091270011422231","volume":"52","author":"PM Jauslin","year":"2012","unstructured":"Jauslin PM, Karlsson MO, Frey N. Identification of the mechanism of action of a glucokinase activator from oral glucose tolerance test data in type 2 diabetic patients based on an integrated glucose\u2010insulin model. J Clin Pharmacol. 2012;52(12):1861\u201371. https:\/\/doi.org\/10.1177\/0091270011422231.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"1245_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10928-012-9281-1","volume":"40","author":"S Choy","year":"2013","unstructured":"Choy S, H\u00e9nin E, Van Der Walt JS, Kjellsson MC, Karlsson MO. Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model. J Pharmacokinet Pharmacodyn. 2013;40(1):1\u201310. https:\/\/doi.org\/10.1007\/s10928-012-9281-1.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"1245_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10928-012-9286-9","volume":"40","author":"X Zhang","year":"2013","unstructured":"Zhang X, Schneck K, Bue-Valleskey J, Yeo KP, Heathman M, Sinha V. Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator. J Pharmacokinet Pharmacodyn. 2013;40(1):53\u201365. https:\/\/doi.org\/10.1007\/s10928-012-9286-9.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"1245_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1463-1326.2011.01365.x","volume":"13","author":"P Barrington","year":"2011","unstructured":"Barrington P, Chien JY, Tibaldi F, Showalter HDH, Schneck K, Ellis B. LY2189265, a long\u2010acting glucagon\u2010like peptide\u20101 analogue, showed a dose\u2010dependent effect on insulin secretion in healthy subjects. Diabetes Obes Metab. 2011;13(5):434\u20138. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01365.x.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1245_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/bcpt.13868","volume":"133","author":"SR Mim","year":"2023","unstructured":"Mim SR, Hussein H, Vidadi S, Leisegang R, Karamchand S, Rambiritch V, et al. Optimal dosing of gliclazide\u2014a model\u2010based approach. Basic Clin Pharmacol Toxicol. 2023;133(1):59\u201372. https:\/\/doi.org\/10.1111\/bcpt.13868.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"1245_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/psp4.11","volume":"4","author":"R R\u00f8ge","year":"2015","unstructured":"R\u00f8ge R, Klim S, Ingwersen S, Kjellsson M, Kristensen N. The effects of a GLP\u20101 analog on glucose homeostasis in type 2 diabetes mellitus quantified by an integrated glucose insulin model. CPT Pharmacomet Syst Pharmacol. 2015;4(1):28\u201336. https:\/\/doi.org\/10.1002\/psp4.11.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"1","key":"1245_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0009-8981(75)90216-8","volume":"59","author":"HC Holtkamp","year":"1975","unstructured":"Holtkamp HC, Verhoef NJ, Leijnse B. The difference between the glucose concentrations in plasma and whole blood. Clin Chim Acta. 1975;59(1):41\u20139. https:\/\/doi.org\/10.1016\/0009-8981(75)90216-8.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1245_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10928-008-9088-2","volume":"35","author":"C Dansirikul","year":"2008","unstructured":"Dansirikul C, Silber HE, Karlsson MO. Approaches to handling pharmacodynamic baseline responses. J Pharmacokinet Pharmacodyn. 2008;35(3):269\u201383. https:\/\/doi.org\/10.1007\/s10928-008-9088-2.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"7","key":"1245_CR38","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00125-006-0273-9","volume":"49","author":"J Radziuk","year":"2006","unstructured":"Radziuk J, Pye S. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? Diabetologia. 2006;49(7):1619\u201328. https:\/\/doi.org\/10.1007\/s00125-006-0273-9.","journal-title":"Diabetologia"},{"issue":"5","key":"1245_CR39","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1177\/193229680900300528","volume":"3","author":"DB Keenan","year":"2009","unstructured":"Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol. 2009;3(5):1207\u201314. https:\/\/doi.org\/10.1177\/193229680900300528.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"1245_CR40","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1177\/1932296815590154","volume":"1","author":"G Schmelzeisen-Redeker","year":"2015","unstructured":"Schmelzeisen-Redeker G, Schoemaker M, Kirchsteiger H, Freckmann G, Heinemann L, Del Re L. Time delay of CGM sensors: relevance, causes, and countermeasures. J Diabetes Sci Technol. 2015;1(5):1006\u201315. https:\/\/doi.org\/10.1177\/1932296815590154.","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"1245_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/jcph.899","volume":"57","author":"LS Tham","year":"2017","unstructured":"Tham LS, Schneck K, Ertekin A, Reviriego J. Modeling pharmacokinetic profiles of insulin regimens to enhance understanding of subcutaneous insulin regimens: journal of clinical pharmacology. J Clin Pharmacol. 2017;57(9):1126\u201337. https:\/\/doi.org\/10.1002\/jcph.899.","journal-title":"J Clin Pharmacol"},{"key":"1245_CR42","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [Internet]. R Foundation for Statistical Computing; 2021. Available from: https:\/\/www.R-project.org. Accessed 18 Mar 2026."},{"key":"1245_CR43","volume-title":"NONMEM 7.5 Users Guides","author":"SL Beal","year":"2020","unstructured":"Beal SL, Sheiner LB, Boeckmann AJ, Bauer RJ. NONMEM 7.5 Users Guides. Gaithersburg, MD: ICON plc; 2020."},{"issue":"3","key":"1245_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson N. PsN-toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79(3):241\u201357. https:\/\/doi.org\/10.1016\/j.cmpb.2005.04.005.","journal-title":"Comput Methods Programs Biomed"},{"key":"1245_CR45","unstructured":"Tobias A, Ballard BD, Mohiuddin SS. Physiology, water balance. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 [cited 2026 Mar 23]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541059\/."},{"issue":"5","key":"1245_CR46","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","volume":"163","author":"D Zeevi","year":"2015","unstructured":"Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079\u201394. https:\/\/doi.org\/10.1016\/j.cell.2015.11.001.","journal-title":"Cell"},{"key":"1245_CR47","unstructured":"Reynolds A, Mitri J. Dietary advice for individuals with diabetes. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279012\/."},{"issue":"1","key":"1245_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/0278-6133.4.1.1","volume":"4","author":"J Rodin","year":"1985","unstructured":"Rodin J. Insulin levels, hunger, and food intake: an example of feedback loops in body weight regulation. Health Psychol. 1985;4(1):1\u201324. https:\/\/doi.org\/10.1037\/0278-6133.4.1.1.","journal-title":"Health Psychol"},{"issue":"12","key":"1245_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/00002018-200730120-00005","volume":"30","author":"K Hermansen","year":"2007","unstructured":"Hermansen K, Mortensen LS. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus. Drug Saf. 2007;30(12):1127\u201342. https:\/\/doi.org\/10.2165\/00002018-200730120-00005.","journal-title":"Drug Saf"},{"issue":"11","key":"1245_CR50","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.2337\/diacare.23.11.1666","volume":"1","author":"P Raskin","year":"2000","unstructured":"Raskin P, Klaff L, Bergenstal R, Hall\u00e9 JP, Donley D, Mecca T. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care. 2000;1(11):1666\u201371. https:\/\/doi.org\/10.2337\/diacare.23.11.1666.","journal-title":"Diabetes Care"},{"issue":"12","key":"1245_CR51","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","volume":"1","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;1(12):2669\u2013701. https:\/\/doi.org\/10.2337\/dci18-0033.","journal-title":"Diabetes Care"},{"key":"1245_CR52","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S26889","volume":"4","author":"C Morello","year":"2011","unstructured":"Morello C. Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. Int J Gen Med. 2011;827. https:\/\/doi.org\/10.2147\/IJGM.S26889.","journal-title":"Int J Gen Med"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01245-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:03:37Z","timestamp":1779847417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01245-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01245-8","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Professor Kjellsson and Mrs. Kunina declare no conflicts of interest. Dr. Chien, Dr. Garhyan, and Dr. Geiser are employees and stockholders of Eli Lilly & Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There were AI-assisted improvements to human generated texts to improve readability.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"A.I. Disclosure Statement"}}],"article-number":"97"}}